Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuropsychopharmacology

• Publication date

  2011-02-16

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/npp.2011.13PMID 21326194PMCID PMC3079839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neurobiology of depression.

  2012cited by this paper
• The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

  2010influential reference
• A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain.

  2010cited by this paper
• Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

  2009cited by this paper
• The 5-HT7 receptor and disorders of the nervous system: an overview

  2009cited by this paper
• Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression

  2009cited by this paper
• The 5-HT7 receptor is involved in allocentric spatial memory information processing.

  2009cited by this paper
• Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice.

  2009cited by this paper
• The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling

  2009cited by this paper
• Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

  2009cited by this paper
• Therapeutic potential of 5-HT7 receptors in mood disorders.

  2009cited by this paper
• Novel quinazolinone derivatives as 5-HT7 receptor ligands.

  2008cited by this paper
• Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats.

  2008cited by this paper
• Lasting Syndrome of Depression Produced by Reduction in Serotonin Uptake during Postnatal Development: Evidence from Sleep, Stress, and Behavior

  2008cited by this paper
• Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise

  2008cited by this paper
• The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.

  2008cited by this paper
• Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents

  2007influential reference
• Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

  2007cited by this paper
• R-citalopram prevents the neuronal adaptive changes induced by escitalopram

  2007cited by this paper
• 5-HT7 receptor antagonists as a new class of antidepressants.

  2007cited by this paper
• Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors

  2007cited by this paper
• Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.

  2007influential reference
• Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.

  2007cited by this paper
• Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.

  2006influential reference
• Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine.

  2006cited by this paper
• Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.

  2006cited by this paper
• Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter

  2006cited by this paper
• Long-term adaptive changes induced by serotonergic antidepressant drugs

  2006cited by this paper
• Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT.

  2006cited by this paper
• The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer

  2005cited by this paper
• Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain

  2005cited by this paper
• 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.

  2005cited by this paper
• The olfactory bulbectomised rat as a model of depression.

  2005influential reference
• Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.

  2005cited by this paper
• Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: Single-cell studies in the rat

  2004cited by this paper
• Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives.

  2004cited by this paper
• Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice

  2004influential reference
• Neurotrophic effects of antidepressant drugs.

  2004cited by this paper
• Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus

  2004cited by this paper
• Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

  2004cited by this paper
• R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.

  2004cited by this paper
• Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment

  2004cited by this paper
• R‐citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter

  2004cited by this paper
• In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.

  2004cited by this paper
• 5-HT1 receptors.

  2004cited by this paper
• 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.

  2004cited by this paper
• A 5-HT7 Heteroreceptor-Mediated Inhibition of [3H]Serotonin Release in Raphe Nuclei Slices of the Rat: Evidence for a Serotonergic–Glutamatergic Interaction

  2004cited by this paper
• Functional, molecular and pharmacological advances in 5-HT7 receptor research.

  2004cited by this paper
• Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants

  2003cited by this paper
• SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats

  2003cited by this paper
• Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment

  2003cited by this paper
• Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

  2003cited by this paper
• Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

  2002cited by this paper
• Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.

  2002cited by this paper
• Differential Regulation of 5-HT1A Receptor-G Protein Interactions in Brain Following Chronic Antidepressant Administration

  2002cited by this paper
• Role of 5-HT2 receptors in the tryptamine-induced 5-HT syndrome in rats

  2002influential reference
• Neurobiology of depression.

  2002cited by this paper
• Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor.

  2002cited by this paper
• Differences in behavior and monoamine laterality following neonatal clomipramine treatment.

  2002cited by this paper
• Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus.

  2001cited by this paper
• Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus

  2001cited by this paper
• Regulation of Adult Neurogenesis by Antidepressant Treatment

  2001cited by this paper
• Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat

  2000influential reference
• Increased Tonic Activation of Rat Forebrain 5-HT1A Receptors by Lithium Addition to Antidepressant Treatments

  2000cited by this paper
• Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors.

  2000cited by this paper
• Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.

  2000cited by this paper
• Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat

  2000cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• Behavioral characteristics of olanzapine: an atypical neuroleptic.

  2000cited by this paper
• Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus

  1999cited by this paper
• Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic Disorders

  1999cited by this paper
• Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors

  1998influential reference
• Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.

  1998cited by this paper
• NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice.

  1998cited by this paper
• Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.

  1998influential reference
• The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat

  1998cited by this paper
• Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?

  1997influential reference
• Olfactory bulbectomy enhances sensitization of the acoustic startle reflex produced by acute or repeated stress.

  1997cited by this paper
• Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.

  1997cited by this paper
• Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation

  1996cited by this paper
• Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

  1995cited by this paper
• Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.

  1995cited by this paper
• Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brain

  1995cited by this paper
• Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression.

  1995cited by this paper
• Pre‐ and post‐synaptic effects of the 5‐HT3 agonist 2‐Methyl‐5‐HT on the 5‐HT system in the rat brain

  1995cited by this paper
• Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment.

  1995cited by this paper
• Current advances and trends in the treatment of depression.

  1994influential reference
• Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.

  1994cited by this paper
• Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

  1993cited by this paper
• Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.

  1992cited by this paper
• Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats.

  1990influential reference
• Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.

  1990cited by this paper
• Animal depression model by neonatal clomipramine: reduction of shock induced aggression.

  1988cited by this paper
• Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain

  1987cited by this paper
• Short‐term lithium treatment enhances responsiveness of postsynaptic 5‐HT1A receptors without altering 5‐HT autoreceptor sensitivity: An electrophysiological study in the rat brain

  1987cited by this paper
• Electrophysiology of Hippocampal Neurons

  1987influential reference
• Increased adult behavioral 'despair' in rats neonatally exposed to desipramine or zimeldine: an animal model of depression?

  1987cited by this paper
• In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals

  1986influential reference
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Mapping the Evolution of the Rat Forced Swim Test across Interpretation, Welfare and Pharmacology.

  2026cites this paper
• 2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities.

  2026cites this paper
• Differential Effects of 5-HT7 Receptor Signaling in the Noradrenergic System in a Rat Model of Treatment-Resistant Depression

  2026influential citation
• Protective Effects of Curcuma longa L. on Corticosterone-Induced Neurotoxicity and Anti-Depression-Like Behavior: Involvement of NMDA and 5-HT7A Receptors

  2025cites this paper
• Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.

  2025cites this paper
• Current drug targets for the treatment of depression

  2025cites this paper
• Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities

  2025cites this paper
• LSD: Mechanisms and Relevance to the Treatment of Depression.

  2025cites this paper
• 5-HT7 Receptors: New Horizons in the Therapy of Neuropsychiatric and Neurodegenerative Diseases

  2025cites this paper
• Gut Microbial Control of Neurotransmitters and Their Relation to Neurological Disorders: A Comprehensive Review

  2025cites this paper
• The 5-HT7 receptor antagonist SB 269970 ameliorates maternal fluoxetine exposure-induced impairment of synaptic plasticity in the prefrontal cortex of the offspring female mice

  2024cites this paper
• The use of serotonin type 7 receptor antagonists as a pharmacological intervention in chronic stress. Insights from animal studies.

  2024cites this paper
• DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects

  2024influential citation
• An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents

  2024cites this paper
• Behavioral Consequences of Hippocampal 5‐HT7 Receptors Blockade in Stressed Rats

  2024cites this paper
• Targeting serotonin receptors with phytochemicals – an in-silico study

  2024cites this paper
• The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review

  2023cites this paper
• Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation

  2023cites this paper
• Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

  2023cites this paper
• Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone

  2023cites this paper
• SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?

  2023cites this paper
• Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders

  2023cites this paper
• Habenula as a Possible Target for Treatment-Resistant Depression Phenotype in Wistar Kyoto Rats

  2022cites this paper
• Serotonergic mechanisms associated with experimental models of hypoxia: A systematic review

  2022cites this paper
• Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases

  2022cites this paper
• Efficacy of the Integrative Acupuncture and Moxibustion Treatment in Patients With Major Depressive Disorder: The Study Protocol for a Multicenter, Single-Blinded, Randomized Trial in China

  2022cites this paper
• GPCR signaling: role in mediating the effects of early adversity in psychiatric disorders

  2021cites this paper
• Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

  2021cites this paper
• Evidence of an antidepressant-like effect of xylopic acid mediated by serotonergic mechanisms

  2021cites this paper
• Multiple facets of serotonergic modulation.

  2021cites this paper
• Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action

  2021influential citation
• The Roles of Serotonin in Neuropsychiatric Disorders

  2021cites this paper
• Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy

  2021cites this paper
• Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor

  2021cites this paper
• Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition

  2020cites this paper
• Revisiting the behavioral genetics of serotonin: relevance to anxiety and depression

  2020cites this paper
• Attenuation of stress-induced behavioral changes by activation of serotonin type 7 receptors in the median raphe nucleus of rats

  2020influential citation
• Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: A review of findings in humans and rodent models.

  2020cites this paper
• Chronic fluoxetine treatment impairs motivation and reward learning by affecting neuronal plasticity in the central amygdala

  2020cites this paper
• The relationship of olfactory function and clinical traits in major depressive disorder.

  2020cites this paper
• 5-HT7 receptors increase the excitability of hippocampal CA1 pyramidal neurons by inhibiting the A-type potassium current.

  2020cites this paper
• Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers.

  2019cites this paper
• Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex.

  2019cites this paper
• Novel antagonists of 5‐HT6 and/or 5‐HT7 receptors affect the brain monoamines metabolism and enhance the anti‐immobility activity of different antidepressants in rats

  2019cites this paper
• Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes: a systematic review and meta-analyses of animal studies

  2019cites this paper
• Investigation of the Mechanisms of Action of Ketamine on the Monoamine Systems: Electrophysiological Studies on the Rat Brain

  2019cites this paper
• Cyanobacterial extract with serotonin receptor subtype 7 (5‐HT7R) affinity modulates depression and anxiety‐like behavior in mice

  2018cites this paper
• Serotonin receptors in depression and anxiety: Insights from animal studies

  2018cites this paper
• The 5-HT7 receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT7 receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus

  2018cites this paper
• MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation.

  2018cites this paper
• Characterization of G-protein coupled receptors in pain, depression and anxiety

  2018cites this paper
• Hypidone Hydrochloride (YL-0919) Produces a Fast-Onset Reversal of the Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

  2018cites this paper
• Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update.

  2018cites this paper
• Antidepressant-like effect of active fraction of Polyrhachisvicina Roger in a rat depression model.

  2018cites this paper
• Antidepressant-like effect of active fraction of Polyrhachisvicina Roger in a rat depressionmodel

  2018cites this paper
• 1 Structure − Activity Relationships and Therapeutic Potentials of 5 ‑ HT 7 2 Receptor Ligands: An Update

  2018cites this paper
• Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.

  2018cites this paper
• Pharmacology and Therapeutic Potential of the 5-HT7 Receptor.

  2018cites this paper
• Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice

  2017cites this paper
• Single Administration of HBK-15—a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone

  2017cites this paper
• Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis

  2017cites this paper
• Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions

  2017cites this paper
• Alteration of Monoaminergic Neuronal Firing by Acute Administration of Cariprazine: An In Vivo Electrophysiological Study

  2017cites this paper
• Asenapine modulates mood‐related behaviors and 5‐HT1A/7 receptors‐mediated neurotransmission

  2017cites this paper
• 5‐HT7 receptor shapes spinogenesis in cortical and striatal neurons

  2017cites this paper
• [Pharmacological properties of vortioxetine and its pre-clinical consequences].

  2016cites this paper
• Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.

  2016cites this paper
• Aporphine Alkaloids as Ligands for Serotonin Receptors

  2016cites this paper
• AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

  2016cites this paper
• Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis

  2016cites this paper
• Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.

  2016cites this paper
• [The pharmacological basis of the serotonin system: Application to antidepressant response].

  2016cites this paper
• Antipsychotics as antidepressants

  2016cites this paper
• The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders

  2016cites this paper
• Tactical Approaches to Interconverting GPCR Agonists and Antagonists.

  2016cites this paper
• 3D QSAR Study of 2-Methoxyphenylpiperazinylakanamides as 5-Hydroxytryptamine (Serotonin) Receptor 7 Antagonists

  2016cites this paper
• Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date

  2015cites this paper
• Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na+, K+-ATPase/Mg2+-ATPase imbalances in spinal cord-injured male rats

  2015cites this paper
• Protein Kinase C Inhibition Rescues Manic-Like Behaviors and Hippocampal Cell Proliferation Deficits in the Sleep Deprivation Model of Mania

  2015cites this paper
• Faster, better, stronger: towards new antidepressant therapeutic strategies.

  2015cites this paper
• Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties

  2015cites this paper
• The 5-HT7 receptor as a potential target for treating drug and alcohol abuse

  2015cites this paper
• 5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin

  2015cites this paper
• Criticisms of drugs in early development for the treatment of depression: what can be improved?

  2015cites this paper
• Serotonin and exercise-induced brain plasticity

  2015cites this paper
• Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain

  2015cites this paper
• Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.

  2015cites this paper
• The 5-HT 7 receptor as a potential target for treating drug and alcohol abuse

  2015cites this paper
• Genetic variations in the serotonergic system contribute to amygdala volume in humans

  2015cites this paper
• Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation

  2015cites this paper
• imbalances in spinal cord-injured male rats

  2015cites this paper
• Retraction note: Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na+, K+-ATPase/Mg2+ ATPase imbalances in spinal cord-injured male rats

  2015cites this paper
• S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior.

  2015cites this paper
• Major Depressive Disorder in the Primary Care Setting: Strategies to Achieve Remission and Recovery.

  2015cites this paper
• Five potential therapeutic agents as antidepressants: a brief review and future directions

  2015cites this paper
• Molecular imaging of the serotonin 5-HT7 receptors: from autoradiography to positron emission tomography

  2014cites this paper
• Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study

  2014influential citation
• The ups and downs of modelling mood disorders in rodents.

  2014cites this paper
• 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders

  2014cites this paper
• Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy

  2014cites this paper